Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment
Titel:
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment
Auteur:
Llovet, Josep M. Vogel, Arndt Madoff, David C. Finn, Richard S. Ogasawara, Sadahisa Ren, Zhenggang Mody, Kalgi Li, Jerry J. Siegel, Abby B. Dubrovsky, Leonid Kudo, Masatoshi